Jay Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jay Patel has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Issa Pour-Ghaz
Division of Cardiovascular Disease, University of Tennessee Health Science Center, Memphis, TN 38103, USA
2 shared publications - Anandbir Singh Bath
Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA
1 shared publication - Arnab Das
Department of Cardiovascular Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA
1 shared publication - Christopher D. Jackson
From the Department of Medicine, Division of General Internal Medicine, University of Tennessee Health Science Center, Memphis
1 shared publication - David Wilbanks
Department of Cardiovascular Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, USA
1 shared publication - Deya Alkhatib
Department of Medicine, Division of Cardiovascular Medicine, Medical College of Georgia at Augusta University, Augusta, Georgia, USA; Department of Radiology, Medical College of Georgia at Augusta University, Augusta, Georgia, USA
1 shared publication
Latest Publications
- Open Access
- 9 December 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (12) , 448
Barth Syndrome: Psychosocial Impact and Quality of Life Assessment
Background: Barth syndrome (BTHS) is a rare X-linked genetic disease that affects multiple systems and leads to complex clinical manifestations. Although a considerable amount of research has focused on the physical aspects of the disease, less has focused on the psychosocial impact and quality of life (QoL) in BTHS. Methods: The current study investigated caregiver- (n = 10) and self-reported (n = 16) psychological well-being and QoL in a cohort of BTHS-affected patients and families. Participants completed the depression and anxiety components of the Patient-Reported Outcomes Information System (PROMIS) Short Form 8A and Health-related quality of life (HRQoL) surveys at enrollment and again during a follow-up period ranging from 6 to 36 months after baseline. Results: Quality of life changed significantly over time and the various domains with some improvement and some decline. Among the available caregiver-patient dyad data, there was a trend toward discordance between caregiver and self-reported outcomes. Most notably, patients reported improvement in HRQoL, while caregivers reported declines. This suggests that there may be differences in perceived quality of life between the patients and parents, though our study is limited by small sample size. Conclusion: Our study provides valuable insights into the impacts of psychosocial and mental health aspects of BTHS. Implications of these findings include incorporating longitudinal assessment of QoL and screening for psychological symptoms in BTHS care to identify interventions that may drastically impact health status and the course of the disease.
- 9 December 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (12) , 448
Open AccessBarth Syndrome: Psychosocial Impact and Quality of Life Assessment
Background: Barth syndrome (BTHS) is a rare X-linked genetic disease that affects multiple systems and leads to complex clinical manifestations. Although a considerable amount of research has focused on the physical aspects of the disease, less has focused on the psychosocial impact and quality of life (QoL) in BTHS. Methods: The current study investigated caregiver- (n = 10) and self-reported (n = 16) psychological well-being and QoL in a cohort of BTHS-affected patients and families. Participants completed the depression and anxiety components of the Patient-Reported Outcomes Information System (PROMIS) Short Form 8A and Health-related quality of life (HRQoL) surveys at enrollment and again during a follow-up period ranging from 6 to 36 months after baseline. Results: Quality of life changed significantly over time and the various domains with some improvement and some decline. Among the available caregiver-patient dyad data, there was a trend toward discordance between caregiver and self-reported outcomes. Most notably, patients reported improvement in HRQoL, while caregivers reported declines. This suggests that there may be differences in perceived quality of life between the patients and parents, though our study is limited by small sample size. Conclusion: Our study provides valuable insights into the impacts of psychosocial and mental health aspects of BTHS. Implications of these findings include incorporating longitudinal assessment of QoL and screening for psychological symptoms in BTHS care to identify interventions that may drastically impact health status and the course of the disease.
- 7 August 2021
- Published by Elsevier in Journal of the National Medical Association
- Vol. 113 (6) , 680-682
The great masquerader: Kikuchi-Fujimoto disease presenting as fever of unknown origin
- 7 August 2021
- Published by Elsevier in Journal of the National Medical Association
- Vol. 113 (6) , 680-682
The great masquerader: Kikuchi-Fujimoto disease presenting as fever of unknown origin
- Open Access
Cardiac Sarcoidosis: Pathophysiology, Diagnosis, and Management
Sarcoidosis is a chronic multi-system disorder with an unknown etiology that can affect the cardiac tissue, resulting in Cardiac Sarcoidosis (CS). The majority of these CS cases are clinically silent, and when there are symptoms, the symptoms are vague and can have a lot in common with other common cardiac diseases. These symptoms can range from arrhythmias to heart failure. If CS goes undetected, it can lead to detrimental outcomes for patients. Diagnosis depends on timely utilization of imaging modalities and non-invasive testing, while in some cases, it does necessitate biopsy. Early diagnosis and treatment with immunosuppressive agents are crucial, and it is essential that follow-up testing be performed to ensure resolution and remission. This manuscript provides an in-depth review of CS and the current literature regarding CS diagnosis and treatment.
Open AccessCardiac Sarcoidosis: Pathophysiology, Diagnosis, and Management
Sarcoidosis is a chronic multi-system disorder with an unknown etiology that can affect the cardiac tissue, resulting in Cardiac Sarcoidosis (CS). The majority of these CS cases are clinically silent, and when there are symptoms, the symptoms are vague and can have a lot in common with other common cardiac diseases. These symptoms can range from arrhythmias to heart failure. If CS goes undetected, it can lead to detrimental outcomes for patients. Diagnosis depends on timely utilization of imaging modalities and non-invasive testing, while in some cases, it does necessitate biopsy. Early diagnosis and treatment with immunosuppressive agents are crucial, and it is essential that follow-up testing be performed to ensure resolution and remission. This manuscript provides an in-depth review of CS and the current literature regarding CS diagnosis and treatment.